Literature DB >> 10688971

Modulatory effect of endogenous and exogenous opioids on the excitatory reflex pathway of the rat ileum.

H D Allescher1, M Storr, C Brechmann, A Hahn, V Schusdziarra.   

Abstract

The ascending excitatory reflex is part of the peristaltic reflex, an important participant in intestinal propulsion. The aim of this study was to characterize the role of different opioid receptors in the ascending reflex through exogenous application of non-selective (Met-enkephalin) and selective opioid agonists (mu-PLO17, delta-DPDPE, kappa-U-50, 488) as well as selective opioid receptor antagonists (mu: CTOP-NH(2), delta: ICI-174,864, kappa: Nor-Binaltorphimine). Metenkephalin (IC(50): 0.06 microM) and morphine (IC(50): 1.8 microM) inhibited the ascending reflex response concentration-dependently. Both the mu-selective agonist PLO17 (IC(50): 0.83 microM, n =11) and the kappa-selective agonist U-50,488 (IC(50): 0.68 microM, n =8) concentration-dependently inhibited the magnitude of the ascending contractile reflex response, whereas the delta-agonist DPDPE (10(-10)-10(-6)M) had no significant effect. In contrast, the latency of the response (time interval between start of the stimulus and onset of the contraction) was significantly prolonged by PLO17 > morphine > Met-enkephalin > DPDPE, whereas U-50,488 showed no effect. When the effect of the receptor-specific antagonists was tested, only CTOP-NH(2)and Nor-BNI caused a significant increase of the contractile response, whereas ICI-174 864 was ineffective. On the other hand, CTOP-NH(2)> ICI-174 864 decreased the latency significantly but the kappa-receptor agonist Nor-BNI had no influence. Thus, mu- and kappa-receptors seem to be involved in regulating the contraction strength of the ascending reflex, whereas both mu- and delta-receptors seem to be involved in the timing of the reflex response. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10688971     DOI: 10.1054/npep.1999.0789

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  8 in total

1.  Involvement of mu- and kappa-, but not delta-, opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea-pig intestine.

Authors:  Anaid Shahbazian; Akos Heinemann; Helmut Schmidhammer; Eckhard Beubler; Ulrike Holzer-Petsche; Peter Holzer
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

2.  Nociceptin effect on intestinal motility depends on opioid-receptor like-1 receptors and nitric oxide synthase co-localization.

Authors:  Andrei Sibaev; Jakub Fichna; Dieter Saur; Birol Yuece; Jean-Pierre Timmermans; Martin Storr
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

Review 3.  Opioid-induced bowel dysfunction: pathophysiology and potential new therapies.

Authors:  Andrea Kurz; Daniel I Sessler
Journal:  Drugs       Date:  2003       Impact factor: 9.546

4.  Methylnaltrexone in the treatment of opioid-induced constipation.

Authors:  Beverley Greenwood-Van Meerveld; Kelly M Standifer
Journal:  Clin Exp Gastroenterol       Date:  2008-12-14

5.  Modulatory effect of adenosine receptors on the ascending and descending neural reflex responses of rat ileum.

Authors:  Martin Storr; Jutta Thammer; Ralf Dunkel; Volker Schusdziarra; Hans-Dieter Allescher
Journal:  BMC Neurosci       Date:  2002-12-20       Impact factor: 3.288

6.  Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design.

Authors:  John Broad; Damien Maurel; Victor W S Kung; Gareth A Hicks; Michael Schemann; Michael R Barnes; Terrence P Kenakin; Sébastien Granier; Gareth J Sanger
Journal:  Sci Rep       Date:  2016-08-05       Impact factor: 4.379

7.  Characterization of putative interneurons in the myenteric plexus of human colon.

Authors:  Adam Humenick; Bao Nan Chen; David A Wattchow; Vladimir P Zagorodnyuk; Phil G Dinning; Nick J Spencer; Marcello Costa; Simon J H Brookes
Journal:  Neurogastroenterol Motil       Date:  2020-08-24       Impact factor: 3.598

8.  Pain therapy with oxycodone/naloxone prolonged-release combination: case report.

Authors:  Feliks Błaszczyk; Aleksandra Droń
Journal:  Contemp Oncol (Pozn)       Date:  2013-10-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.